tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Citi adds ‘upside 90-day catalyst watch’ on Olema Oncology
PremiumThe FlyCiti adds ‘upside 90-day catalyst watch’ on Olema Oncology
8d ago
Olema Oncology rises 6.2%
Premium
The Fly
Olema Oncology rises 6.2%
30d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Promising Potential of Olema Pharmaceuticals’ Palazestrant in Transforming ER+/HER2- Breast Cancer Treatment
PremiumRatingsPromising Potential of Olema Pharmaceuticals’ Palazestrant in Transforming ER+/HER2- Breast Cancer Treatment
1M ago
Positive Outlook for Olema’s OPERA-02 Trial Based on Roche’s Promising Giredestrant Data
Premium
Ratings
Positive Outlook for Olema’s OPERA-02 Trial Based on Roche’s Promising Giredestrant Data
1M ago
Buy Rating for Olema Pharmaceuticals Driven by Promising Oral SERD Potential in Breast Cancer Treatment
Premium
Ratings
Buy Rating for Olema Pharmaceuticals Driven by Promising Oral SERD Potential in Breast Cancer Treatment
1M ago
Olema Oncology price target raised to $40 from $20 at Guggenheim
PremiumThe FlyOlema Oncology price target raised to $40 from $20 at Guggenheim
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Olema Pharmaceuticals Announces Public Stock Offering
Premium
Company Announcements
Olema Pharmaceuticals Announces Public Stock Offering
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100